Follow-The-Filings

Security · featured owners

AGIO Agios Pharmaceuticals Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.1%
  • $228M
  • 1 add

AGIO (Agios Pharmaceuticals Inc.) is held in 2 featured 13F books as of 2026 Q2. Palo Alto Investors is the largest tracked holder by portfolio weight (1.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 1.1%
  2. Farallon Capital Management add 1.0%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management 2026 Q2 1.0% Add +4.1% 5,917,400 $220M history
Palo Alto Investors 2026 Q2 1.1% Hold 213,601 $8M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 6 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Aug 4, 2026 Filing Doc
4 Period Jul 8, 2026 Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 18, 2026 · 15 forms Filing Doc
4 Period Jun 13, 2026 · 2 forms Filing Doc
4 Period Apr 2, 2026 · 5 forms Filing Doc

Updated 10 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $26.82M $36.5M $54.03M
Gross profit * $23.94M $32.33M $47.68M
Gross margin * 89.3% 88.6% 88.3%
Net income -$352.09M $673.72M -$412.78M
Net margin * -1312.6% 1845.9% -764.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $833.84M $965.6M $942.05M
Total non-current assets * $103.28M $697.6M $355.17M
Total assets $0.937B $1.66B $1.3B
Total current liabilities $67.96M $81.16M $82.21M
Total non-current liabilities * $58.14M $41.09M $21.9M
Total equity $0.811B $1.54B $1.19B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$296.06M -$389.84M -$372.98M
Cash from investing $239.58M $363.44M $377.18M
Cash from financing $5.43M $14.44M $8.68M
Net change in cash -$51.05M -$11.96M $12.88M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders